Nurix Therapeutics (NRIX) Profit After Tax (QoQ) (2019 - 2026)
Nurix Therapeutics (NRIX) Profit After Tax (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Nurix Therapeutics | 2.60 Bn | 2.15 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -2.71% |
| Feb 28, 2026 | -11.45% |
| Nov 30, 2025 | 9.49% |
| Aug 31, 2025 | -98.83% |
| May 31, 2025 | 22.87% |
| Feb 28, 2025 | 3.75% |
| Nov 30, 2024 | -19.60% |
| Aug 31, 2024 | -9.90% |
| May 31, 2024 | -7.29% |
| Feb 29, 2024 | 1.04% |
| Nov 30, 2023 | -13.45% |
| Aug 31, 2023 | -52.33% |
| May 31, 2023 | 40.40% |
| Feb 28, 2023 | 12.81% |
| Nov 30, 2022 | -2.21% |
| Aug 31, 2022 | -0.68% |
| May 31, 2022 | -6.74% |
| Feb 28, 2022 | -12.81% |
| Nov 30, 2021 | -30.75% |
| Aug 31, 2021 | -9.30% |